INBRACE Support Program
INBRACE Support Program
I am a

Health plan professional
Formulary or population health decision maker
This site is intended for payers or other professionals who make formulary and/or population health decisions within their organization.
I am a
Formulary or population health decision maker

Please make a selection below

Please choose the best description of your organization

Please enter a valid email address
Invalid User ID

Thank you for registering
Sign Up
Please correct errors below

PLEASE NOTE: Once registered, you will receive a follow-up email confirming access, typically within 2 business days.

By completing and submitting this form, you agree to sign up for communications from Neurocrine Biosciences. You are confirming you understand and agree to the Privacy Policy and Terms and Conditions.

Materials Available for Instant Download

Population Health Resources Overview
An overview of the population health resources available to help manage individuals with movement disorders, particularly TD

2020 APA Schizophrenia Practice Guideline: Managing Antipsychotic-Associated Movement Disorders for Individuals With Mental Illness
2020 APA Practice Guideline for the Treatment of Patients With Schizophrenia suggests baseline and follow-up assessments for antipsychotic-associated movement disorders, including recommendations for the management of TD

Register for access to more Population Health resources for TD and PD.

Register Now
Additional Resources for Registered Users Include:
Patient Screener: Tardive Dyskinesia Means Having Movements You Can’t Control
A list of questions to help with the assessment of abnormal movements in patients taking antipsychotics for at least a few months.
Audience: Patients
Identifying Tardive Dyskinesia in Patients With Serious Mental Illness
Population management considerations for people with serious mental illness taking antipsychotic medication, including TD diagnosis and assessment criteria.
Audience: HCPs, Case Managers, Formulary Decision-Makers
Tardive Dyskinesia: A Clinically Distinct, Drug-Induced Movement Disorder
TD disease awareness information, including diagnosis and management considerations.
Audience: HCPs, Case Managers, Formulary Decision-Makers